Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 5 days, and 1 more · Every feed →

All 43Congress 0Executive branch 0Insiders 43
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

ELVN · $15K+ · 43 trades

Trades
43
Buys 0 · Sells 43
People
8
Stocks
1
Disclosed value
$168M
range midpoints · Congress & executive
Filed late
6
  1. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$66.5Kdisclosed Jun 24 · filed 2 days after the trade
  2. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  3. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  4. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  5. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  6. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  7. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$149Kdisclosed Jun 22 · filed 5 days after the trade · late
  8. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$55.4Kdisclosed Jun 22 · filed 5 days after the trade · late
  9. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$59Kdisclosed Jun 22 · filed 5 days after the trade · late
  10. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$114Kdisclosed Jun 22 · filed 5 days after the trade · late
  11. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$54.3Kdisclosed Jun 22 · filed 5 days after the trade · late
  12. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$50.7Kdisclosed Jun 22 · filed 5 days after the trade · late
  13. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$12.3Mdisclosed Jun 17 · filed 2 days after the trade
  14. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$12.3Mdisclosed Jun 17 · filed 2 days after the trade
  15. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$409Kdisclosed Jun 17 · filed 2 days after the trade
  16. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$409Kdisclosed Jun 17 · filed 2 days after the trade
  17. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$409Kdisclosed Jun 17 · filed 2 days after the trade
  18. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$12.3Mdisclosed Jun 17 · filed 2 days after the trade